CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic CancerDorrah Deeb(Henry Ford Health System), Subhash C. Gautam(Henry Ford Health System)CancersOctober 13, 201010.3390/cancers2041779Cited by 19SaveCiteExport RISWatch citationsRelated PapersInhibition of Telomerase Activity by Oleanane Triterpenoid CDDO-Me in Pancreatic Cancer Cells is ROS-Dependent|Molecules|2013|47Telomerase Reverse Transcriptase (TERT) is a Therapeutic Target of Oleanane Triterpenoid CDDO-Me in Prostate Cancer|Molecules|2012|20